CEO
EpimAb Biotherapeutics, Inc.
Shanghai, Shanghai
Chengbin Wu serves as CEO at EpimAb Biotherapeutics, Inc.. EpimAb Biotherapeutics, Inc. operates in the biotechnology sector with approximately 40.0 employees. The company is headquartered in Shanghai, Shanghai. EpimAb Biotherapeutics, Inc. generates annual revenue of 9300000.0. To date, EpimAb Biotherapeutics, Inc. has raised 219000000.0 in total funding, with the most recent round being Series C.
Chengbin Wu's verified email address is available on MessageCEO. They currently work at EpimAb Biotherapeutics, Inc.. Pro subscribers can access direct email addresses for over 200,000 executives.
Chengbin Wu is CEO at EpimAb Biotherapeutics, Inc., a company in the biotechnology sector with 40.0 employees. The company is based in Shanghai, Shanghai.
Chengbin Wu works in the biotechnology industry as CEO at EpimAb Biotherapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chengbin Wu's profile is kept up-to-date with the latest available information.